Quantifying leukemia
- PMID: 9718385
- DOI: 10.1056/NEJM199808273390911
Quantifying leukemia
Comment on
-
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.N Engl J Med. 1998 Aug 27;339(9):591-8. doi: 10.1056/NEJM199808273390904. N Engl J Med. 1998. PMID: 9718378
Similar articles
-
Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between "molecular" and clinical relapse?Haematologica. 2002 Apr;87(4):ELT19. Haematologica. 2002. PMID: 11940504 No abstract available.
-
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.N Engl J Med. 1998 Aug 27;339(9):591-8. doi: 10.1056/NEJM199808273390904. N Engl J Med. 1998. PMID: 9718378
-
Silence of the leukemic clone.N Engl J Med. 1997 Jan 30;336(5):367-9. doi: 10.1056/NEJM199701303360510. N Engl J Med. 1997. PMID: 9011792 No abstract available.
-
Detection and monitoring of minimal residual disease by quantitative real-time PCR.Clin Chim Acta. 2006 Jan;363(1-2):147-56. doi: 10.1016/j.cccn.2005.05.045. Epub 2005 Sep 8. Clin Chim Acta. 2006. PMID: 16154122 Review.
-
[Detection of minimal residual leukemia using polymerase chain reaction method].Rinsho Byori. 1996 Jun;44(6):535-40. Rinsho Byori. 1996. PMID: 8752731 Review. Japanese.
Cited by
-
Clonality and phenotyping of canine lymphomas before chemotherapy and during remission using polymerase chain reaction (PCR) on lymph node cytologic smears and peripheral blood.Can Vet J. 2010 Jan;51(1):79-84. Can Vet J. 2010. PMID: 20357946 Free PMC article.
-
Detection of the BCR-ABL gene by interphase fluorescence in situ hybridization (iFISH) in chronic myelogenous leukemia patients after hemopoietic stem cell transplantation: the feasibility of iFISH monitoring of therapeutic response in peripheral blood.Int J Hematol. 2002 Aug;76(2):180-5. doi: 10.1007/BF02982582. Int J Hematol. 2002. PMID: 12215018
-
Non-genetic heterogeneity--a mutation-independent driving force for the somatic evolution of tumours.Nat Rev Genet. 2009 May;10(5):336-42. doi: 10.1038/nrg2556. Nat Rev Genet. 2009. PMID: 19337290 Review.
-
Use of real time leukaemia data to validate model predictions based on analyses and computer simulations.Cell Prolif. 2001 Dec;34(6):331-45. doi: 10.1046/j.1365-2184.2001.00218.x. Cell Prolif. 2001. PMID: 11736998 Free PMC article.
-
Molecular monitoring of BCR-ABL transcripts in patients with chronic myelogenous leukemia: is high sensitivity of clinical value?Curr Hematol Malig Rep. 2010 Apr;5(2):88-94. doi: 10.1007/s11899-010-0046-x. Curr Hematol Malig Rep. 2010. PMID: 20425401 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical